These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 20339966)

  • 1. Effects of ramipril on serum monocyte chemoattractant protein 1, interleukin-18, and interleukin-10 in elderly patients with acute coronary syndrome.
    Chen HQ; Tan HY; Yang YW; Qiu L; Liu XQ
    Heart Vessels; 2010 Mar; 25(2):77-81. PubMed ID: 20339966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colchicine Acutely Suppresses Local Cardiac Production of Inflammatory Cytokines in Patients With an Acute Coronary Syndrome.
    Martínez GJ; Robertson S; Barraclough J; Xia Q; Mallat Z; Bursill C; Celermajer DS; Patel S
    J Am Heart Assoc; 2015 Aug; 4(8):e002128. PubMed ID: 26304941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of fluvastatin therapy on serum interleukin-18 and interleukin-10 levels in patients with acute coronary syndrome.
    Liu Y; Jiang H; Liu W; Shang H; Tang Y; Zhu R; Li B
    Acta Cardiol; 2010 Jun; 65(3):285-9. PubMed ID: 20666265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluated plasma interleukin-18/interleukin-10 ratio is a risk factor for acute coronary syndromes in patients with stable angina pectoris.
    Li Q; Li Z; Zhang X; Ruan Y; Qiu J
    Cardiol J; 2014; 21(1):83-8. PubMed ID: 23677727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of inflammation factors in development of acute coronary syndrome in patients with type 2 diabetes mellitus and impaired glucose tolerance].
    Chazova TE; Masenko VP; Zykov KA; Golitsyna TIu
    Ter Arkh; 2007; 79(6):60-4. PubMed ID: 17684970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of interleukin-6 (Il-6), interleukin-18 (Il-18) and C-reactive protein (CRP) in patients with type-2 diabetes and acute coronary syndrome without ST-segment elevation.
    Souza JR; Oliveira RT; Blotta MH; Coelho OR
    Arq Bras Cardiol; 2008 Feb; 90(2):86-90. PubMed ID: 18392379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Angiotensin-converting Enzyme Inhibition Post Revascularization Study (APRES).
    Kjøller-Hansen L; Steffensen R; Grande P
    J Am Coll Cardiol; 2000 Mar; 35(4):881-8. PubMed ID: 10732883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expressions and clinical significance of factors related to acute coronary syndrome.
    Sun H; Zhang J; Zheng Y; Shang S
    J Biol Regul Homeost Agents; 2018; 32(2):299-305. PubMed ID: 29685010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage migration inhibitory factor is enhanced in acute coronary syndromes and is associated with the inflammatory response.
    Müller II; Müller KA; Schönleber H; Karathanos A; Schneider M; Jorbenadze R; Bigalke B; Gawaz M; Geisler T
    PLoS One; 2012; 7(6):e38376. PubMed ID: 22693633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of low dose atorvastatin on inflammatory marker levels in patients with acute coronary syndrome and its potential clinical value.
    Lewandowski M; Kornacewicz-Jach Z; Millo B; Zielonka J; Czechowska M; Kaliszczak R; Płońska E; Goracy J; Kaźmierczak J; Naruszewicz M
    Cardiol J; 2008; 15(4):357-64. PubMed ID: 18698545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-18: an independent predictor of cardiovascular events in patients with acute coronary syndrome after 6 months of follow-up.
    Furtado MV; Rossini AP; Campani RB; Meotti C; Segatto M; Vietta G; Polanczyk CA
    Coron Artery Dis; 2009 Aug; 20(5):327-331. PubMed ID: 19593889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the antihypertensive and anti-inflammatory effects of aliskiren and ramipril add-on therapy in peritoneal dialysis patients--a pilot open label study.
    Makówka A; Olejniczak-Fortak M; Nowicki M
    Kidney Blood Press Res; 2012; 36(1):18-25. PubMed ID: 22777192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated plasma IL-37, IL-18, and IL-18BP concentrations in patients with acute coronary syndrome.
    Ji Q; Zeng Q; Huang Y; Shi Y; Lin Y; Lu Z; Meng K; Wu B; Yu K; Chai M; Liu Y; Zhou Y
    Mediators Inflamm; 2014; 2014():165742. PubMed ID: 24733959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of interleukin-33 and interleukin-6 in patients with acute coronary syndrome or stable angina.
    Liu CL; Shen DL; Zhu K; Tang JN; Hai QM; Zhang JY
    Clin Invest Med; 2013 Aug; 36(4):E234-41. PubMed ID: 23906495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Angiotensin-Converting Enzyme Inhibition and Alpha 1-Adrenergic Receptor Blockade on Inflammation and Hemostasis in Human Hypertension.
    Ekholm M; Jekell A; Wallén NH; Gigante B; Kahan T
    J Cardiovasc Pharmacol; 2018 Apr; 71(4):240-247. PubMed ID: 29389738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk stratification for heart failure and death in an acute coronary syndrome population using inflammatory cytokines and N-terminal pro-brain natriuretic peptide.
    Kavsak PA; Ko DT; Newman AM; Palomaki GE; Lustig V; MacRae AR; Jaffe AS
    Clin Chem; 2007 Dec; 53(12):2112-8. PubMed ID: 17932131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of serum levels of inflammatory markers in patients with coronary vasospasm without significant fixed coronary artery disease versus patients with stable angina pectoris and acute coronary syndromes with significant fixed coronary artery disease.
    Hung MJ; Cherng WJ; Cheng CW; Li LF
    Am J Cardiol; 2006 May; 97(10):1429-34. PubMed ID: 16679078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac angiotensin II participates in coronary microvessel inflammation of unstable angina and strengthens the immunomediated component.
    Neri Serneri GG; Boddi M; Modesti PA; Coppo M; Cecioni I; Toscano T; Papa ML; Bandinelli M; Lisi GF; Chiavarelli M
    Circ Res; 2004 Jun; 94(12):1630-7. PubMed ID: 15131005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory and anti-inflammatory variable clusters and risk prediction in acute coronary syndrome patients: a factor analysis approach.
    Tziakas DN; Chalikias GK; Kaski JC; Kekes A; Hatzinikolaou EI; Stakos DA; Tentes IK; Kortsaris AX; Hatseras DI
    Atherosclerosis; 2007 Jul; 193(1):196-203. PubMed ID: 16857204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels of the monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 are elevated in patients with acute myocardial infarction.
    Matsumori A; Furukawa Y; Hashimoto T; Yoshida A; Ono K; Shioi T; Okada M; Iwasaki A; Nishio R; Matsushima K; Sasayama S
    J Mol Cell Cardiol; 1997 Jan; 29(1):419-23. PubMed ID: 9040055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.